Breast cancer is less common before age 40, but
being young does not rule it out. Because routine mammography usually has not started for average-risk women in their 20s and 30s, recognizing breast changes and understanding your personal risk are especially important.
A new or persistent breast lump, nipple or skin change, unusual discharge or other unexplained breast change should be medically evaluated regardless of age. Women at higher risk may also need breast cancer screening earlier than the general population.
Key Takeaways
- Breast cancer before 40 is uncommon, but it can occur.
- New or persistent breast changes should be evaluated regardless of age.
- Most average-risk women do not routinely start mammography before 40, while women at higher risk may need earlier mammography, breast MRI or both.
What breast cancer symptoms should younger women watch for?
Many breast changes in younger women are caused by benign conditions such as cysts or fibroadenomas. However, see a doctor if you notice:
- A new breast or underarm lump or thickening
- A persistent change in breast size, shape or contour
- Dimpling, puckering, redness or thickening of the skin
- A nipple that newly turns inward
- Unusual nipple discharge, particularly bloody discharge
- Persistent swelling or another breast change that does not resolve
Breast cancers diagnosed at younger ages can sometimes have more aggressive biological characteristics, making timely investigation of persistent symptoms important.
Who is at higher risk of breast cancer before 40?
Age remains an important breast cancer risk factor, but some younger women have a substantially higher-than-average risk.
Factors that may indicate a need for earlier risk assessment include:
- A parent, sibling or child diagnosed with breast cancer, particularly at a young age
- Multiple relatives with breast, ovarian, pancreatic or prostate cancer
- A known inherited cancer-related gene variant, such as BRCA1, BRCA2, PALB2 or TP53
- Previous radiation therapy to the chest at a young age
- A personal history of breast cancer or certain high-risk breast conditions
The American College of Radiology recommends
breast cancer risk assessment by age 25 so women at increased risk can discuss whether earlier or more intensive screening is appropriate.
Do women under 40 need mammograms?
For most women at
average risk, routine mammography is not generally started before age 40. Screening recommendations are different for women at increased risk and may include earlier mammography, breast MRI or both.
Importantly,
screening is different from investigating a symptom.
If you discover a breast lump before age 40, you should not wait until your routine screening age. Diagnostic imaging can be performed at any age when medically appropriate.
For a palpable breast lump:
- Under age 30: Breast ultrasound is usually the first imaging examination.
- Age 30–39: Breast ultrasound and/or diagnostic mammography or digital breast tomosynthesis (3D mammography) may be appropriate.
- Further imaging or biopsy may be recommended depending on the findings.
What if breast cancer is diagnosed at a young age?
Treatment is individualized according to the cancer type and stage, hormone receptor and HER2 status, genetic findings and overall health.
For younger patients, additional considerations may include genetic counseling and future fertility. Some cancer treatments can affect ovarian function and fertility, so women who may wish to have children in the future should discuss
fertility preservation before treatment begins, when possible.
Why choose Bumrungrad for breast screening and breast care?
At Bumrungrad International Hospital, the
Breast Center works with the
Diagnostic Radiology and Nuclear Medicine Center and
Horizon Regional Cancer Center to support breast screening, diagnosis and treatment.
Services include digital mammography, breast ultrasound, breast MRI, fine-needle aspiration and stereotactic breast biopsy. Bumrungrad also uses
Lunit INSIGHT MMG, an AI-assisted mammography system that supports radiologists by highlighting suspicious regions for closer review.
- Internationally Accredited Care:
Bumrungrad’s Breast Cancer Program received Joint Commission International Clinical Care Program Certification (JCI CCPC) in 2025.
- Global Recognition: In Newsweek and Statista’s Best Specialized Hospitals Asia Pacific 2026, Bumrungrad ranked No. 1 in Thailand and 58th in Asia-Pacific for Oncology. Bumrungrad also ranked No. 96 worldwide in Newsweek’s World’s Best Hospitals 2026 and was the only hospital from Thailand in the global Top 100.
Frequently Asked Questions
Can you get breast cancer in your 20s or 30s?
Yes. Breast cancer is much less common at younger ages, but it can occur. A persistent or unusual breast change should therefore be evaluated regardless of age.
Should I get a mammogram before 40 if breast cancer runs in my family?
Possibly. A strong family history or inherited genetic risk may mean screening should begin earlier and may include breast MRI as well as mammography. Individual risk should be assessed by a healthcare professional.
Is a breast lump in a young woman usually cancer?
No. Many breast lumps in younger women are benign. However, examination and appropriate imaging are needed to determine the cause rather than relying on age or touch alone.
When should I see a doctor about a breast change?
Arrange an assessment if you notice a new, persistent or changing lump, nipple or skin changes, unexplained nipple discharge or another breast change that is unusual for you.
Breast cancer before 40 is uncommon, but awareness matters. Knowing your personal risk and seeking medical evaluation for new or persistent breast changes can help ensure that concerning findings are investigated without unnecessary delay.
References
- Cathcart-Rake EJ, Ruddy KJ, Bleyer A, Johnson RH. Breast cancer in adolescent and young adult women under the age of 40 years. JCO Oncology Practice. 2021;17(6):305–313.
- Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status. JAMA Network Open. 2024;7(1):e2353331.
- Monticciolo DL, Newell MS, Moy L, Lee CS, Destounis SV. Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR. Journal of the American College of Radiology. 2023;20(9):902–914.
- Klein KA, Kocher M, Lourenco AP, et al. ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update. Journal of the American College of Radiology. 2023;20(5S):S146–S163.
- National Cancer Institute. BRCA Gene Changes: Cancer Risk and Genetic Testing.
- Su HI, Lacchetti C, Letourneau J, et al. Fertility preservation in people with cancer: ASCO Guideline Update. Journal of Clinical Oncology. 2025;43(12):1488–1515.
Medically reviewed by:
Piyawan Kensakoo, M.D.
Breast Surgery & General Surgery
Last medically reviewed: September 2026
For more information please contact:
Last modify: September 09, 2026